Author： Schreiber S. Pick C.G.
Publisher： Elsevier
ISSN： 0924-977X
Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 293-294
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Fluoxetine now first line SSRI for paediatric MDD
Inpharma, Vol. 1, Iss. 1419, 2004-01 ,pp. :
Access to resources
Recommend
Fluoxetine used successfully in myasthenic syndrome
Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. :
Sarcoidosis was treated successfully with infliximab
Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. :
Safety and side effect profile of fluoxetine
Expert Opinion on Drug Safety, Vol. 3, Iss. 5, 2004-09 ,pp. :